The Emerging Role and Value of HRD Testing in Ovarian Cancer - EMG

The Emerging Role and Value of HRD Testing in Ovarian Cancer

Bonus Episode

The Emerging Role and Value of HRD Testing in Ovarian Cancer

This episode, sponsored by an educational grant from AstraZeneca, is on the topic of ovarian cancer. Hear from two experts in the field, Professor Frederik Marmé and Professor Christina Fotopoulou, as they discuss the impact of late diagnosis and delayed treatment on patient outcomes, risk reduction strategies, and HRD testing.

Spotify | Apple | Acast

Download MP3 (mp 44:40 mins)

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now